2024 Japan Enteric Disease Market: Shares and Segment Forecasts-Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia

August 2020 | 322 pages | ID: 2306E3F6CCBBEN
Venture Planning Group

Abstracts

About This Report

This new 322-page report from LeadingMarketResearch.com presents detailed analysis of the Japanese Enteric Diseases market, including sales forecasts and supplier shares forCampylobacter,Cryptosporidium,E. Coli,Enterovirus,Rhinovirus,Rotavirus,Salmonella,Shigella,VibrioandYersinia. The report provides test volume and sales projections for Hospitals and Commercial/Private Labs.

The report is available by section, and can be customized to specific information needs and budget.

In addition to market share and sales forecasts, the report:

• Examines market applications of Molecular Diagnostics, Monoclonal Antibodies, Immunoassays, IT and other emerging technologies;
• Reviews features and operating characteristics of major analyzers used for microbiology testing;
• Profiles key suppliers and potential market entrants developing innovative technologies and products; and
• Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues.

Methodology

The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products.

In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as VPGMarketResearch’s proprietary data files was conducted.

Contains 322 pages and 20 tables

Contents

I. INTRODUCTION

II. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. Major Infectious Disease Tests
  1. Campylobacter
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  2. Cryptosporidium
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  3. E. Coli
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  4. Enteroviruses
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  5. RhinoViruses
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  6. RotaVirus (REOVIRUS)
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  7. Salmonellosis
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  8. Shigellosis
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  9. Vibrio
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  10. Yersinia
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
B. Instrumentation Review of Leading Analyzers Marketed by Abbott, Beckman Coulter/Danaher, BioMerieux, Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other Suppliers
C. Emerging Diagnostic Technologies
  1. Molecular Diagnostics
  2. Monoclonal Antibodies
  3. Immunoassays
  4. Differential Light Scattering
  5. Information Technology
  6. Artificial Intelligence
  7. Liposomes
  8. Flow Cytometry
  9. Chromatography
  10. Diagnostic Imaging
  11. Gel Microdroplets
  12. Other

III. MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
  1. Marketing Approaches
  2. Product Complexity
  3. Customer Preference
  4. Established Suppliers
  5. Emerging Suppliers
  6. Major Types of Distributors
  7. Market Segmentation

POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

COMPETITIVE ASSESSMENTS

Abbott
Affymetrix
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biokit
bioMerieux
Bio-Rad
Biotest
Cepheid
Decode Genetics
Diamedix
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Exact Sciences
Fujirebio
Grifols
GSK Biologicals
Hologic
Illumina
LabCorp
Leica Biosystems
Li-Cor Biosciences
Lonza
Myriad Genetics
Ortho-Clinical Diagnostics
PerkinElmer
Proteome Sciences
Qiagen
Roche
Scienion
Sequenom
SeraCare
Shimadzu
Siemens Healthineers
Sierra Molecular
Takara Bio
Tecan Group
Thermo Fisher
Wako